Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey

被引:0
|
作者
Laura C. Coates
Valderilio F. Azevedo
Joseph C. Cappelleri
Jade Moser
Lihi Eder
Pascal Richette
Meng-Yu Weng
Ruben Queiro Silva
Amit Garg
Amar Majjhoo
Christopher E. M. Griffiths
Pamela Young
Samantha Howland
机构
[1] University of Oxford,Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences
[2] Universidade Federal do Paraná,Rheumatology Department
[3] Pfizer Inc,Department of Internal Medicine, Division of Allergy, Immunology, and Rheumatology
[4] The Harris Poll,Rheumatology Division
[5] Women’s College Research Institute,Dermatology Centre, NIHR Manchester Biomedical Research Centre
[6] University of Toronto,undefined
[7] Lariboisière Hospital,undefined
[8] Lariboisière,undefined
[9] University of Paris,undefined
[10] National Cheng Kung University Hospital,undefined
[11] College of Medicine,undefined
[12] National Cheng Kung University,undefined
[13] HUCA,undefined
[14] Donald and Barbara Zucker School of Medicine at Hofstra/Northwell,undefined
[15] Shores Rheumatology,undefined
[16] University of Manchester,undefined
[17] Pfizer Inc,undefined
[18] Pfizer Ltd,undefined
来源
Rheumatology and Therapy | 2021年 / 8卷
关键词
Communication; Health-related quality of life; Patients; Physicians; Psoriatic arthritis; Surveys and questionnaires;
D O I
暂无
中图分类号
学科分类号
摘要
Psoriatic arthritis (PsA) is a disease that can cause swollen and painful joints, as well as skin psoriasis. To effectively treat PsA, it is important that doctors and patients communicate well. We used a survey to ask patients with PsA and doctors from around the world about their communications about PsA. We also asked how PsA affects patients’ quality of life. In total, 1286 patients and 1553 doctors took the survey. Most patients said that PsA affected their social and work lives. Similarly, PsA had a negative impact on physical activity and on emotional and/or mental wellbeing in most patients who answered the survey. Doctors answered similarly, but they were generally less likely to recognize how severely PsA can impact patients, compared with patients themselves. Most patients and doctors were happy with their patient–doctor communication, and most patients felt comfortable talking about their worries and/or fears with their doctor. However, some patients (about four out of 10) felt that communication with their doctors was not good; these patients were less likely/comfortable to talk about their PsA symptoms and the impacts of PsA with their doctor. PsA was also more likely to negatively impact these patients’ quality of life. This survey shows that it is important to find ways to improve communication between patients with PsA and their doctors.
引用
收藏
页码:1741 / 1758
页数:17
相关论文
共 50 条
  • [31] Quality of life of psoriatic arthritis patients treated with etanercept
    Matusiak, Lukasz
    Szepietowski, Jacek
    PRZEGLAD DERMATOLOGICZNY, 2012, 99 (05): : 637 - 646
  • [33] Screening and Referral Strategies for the Early Recognition of Psoriatic Arthritis Among Patients With Psoriasis: Results of a GRAPPA Survey
    Song, Kaiyang
    Webb, Louisa
    Eder, Lihi
    FitzGerald, Oliver
    Goel, Niti
    Helliwell, Philip S.
    Katz, Arnon
    Merola, Joseph F.
    Rosen, Cheryl F.
    Coates, Laura C.
    Poddubnyy, Denis
    JOURNAL OF RHEUMATOLOGY, 2023, 50 (11) : 1439 - 1445
  • [34] Gender Differences in Perceptions of Psoriatic Arthritis Disease Impact, Management, and Physician Interactions: Results from a Global Patient Survey
    Eder, Lihi
    Richette, Pascal
    Coates, Laura C.
    Azevedo, Valderilio F.
    Cappelleri, Joseph C.
    Johnson, Edward P.
    Hoang, Megan
    Moser, Jade
    Kessouri, Meriem
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1115 - 1134
  • [35] SEX DIFFERENCES IN PERCEPTIONS OF PSORIATIC ARTHRITIS DISEASE IMPACT, MANAGEMENT AND PHYSICIAN INTERACTIONS: RESULTS FROM A GLOBAL PATIENT SURVEY
    Eder, L.
    Richette, P.
    Coates, L.
    Azevedo, V. F.
    Cappelleri, J. C.
    Hoang, M.
    Moser, J.
    Kinch, C.
    Kessouri, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 45 - 46
  • [36] National survey of patients with psoriatic arthritis in Spain: disease activity, pharmacological therapy and impact on quality of life
    J D Cañete
    R Rodríguez
    J Ramírez
    Journal of Translational Medicine, 8 (Suppl 1)
  • [37] Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Philip J. Mease
    Pamela Young
    Lara Fallon
    Rajiv Mundayat
    Oluwaseyi Dina
    Taylor Blachley
    Nicole Middaugh
    Alexis Ogdie
    Rheumatology and Therapy, 2024, 11 : 313 - 329
  • [38] Effectiveness of Tofacitinib in Patients Initiating Therapy for Psoriatic Arthritis: Results from the CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry
    Mease, Philip J.
    Young, Pamela
    Fallon, Lara
    Mundayat, Rajiv
    Dina, Oluwaseyi
    Blachley, Taylor
    Middaugh, Nicole
    Ogdie, Alexis
    RHEUMATOLOGY AND THERAPY, 2024, 11 (02) : 313 - 329
  • [39] Discordance of global assessment between the patients and physicians predicts 9-year pain-related outcomes in rheumatoid arthritis patients
    Hayashi, Kazuhiro
    Miki, Kenji
    Shi, Kenrin
    Yukioka, Masao
    Hirayama, Takehiro
    Tsujimoto, Kohei
    Takeuchi, Takao
    Hayaishi, Yasuhisa
    Hayaishi, Masahiro
    FRONTIERS IN MEDICINE, 2023, 10
  • [40] Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey
    Radtke, M. A.
    Reich, K.
    Blome, C.
    Rustenbach, S.
    Augustin, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2009, 23 (06) : 683 - 691